Novartis AG/€NOVN
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Novartis AG
Novartis AG is a global healthcare company based in Switzerland, specializing in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products. The company's core business is centered around patented prescription medicines in areas such as oncology, cardiovascular, immunology, neuroscience, and ophthalmology. Formed in 1996 from the merger of Ciba-Geigy and Sandoz, Novartis operates in over 150 countries worldwide. Its strategic positioning is reinforced by significant investments in research and development, supporting a robust pipeline of innovative therapies. The company is headquartered in Basel, Switzerland, and emphasizes its competitive strength through advanced research capabilities and a diverse product portfolio.
Ticker
€NOVN
Sector
Primary listing
XGAT
Employees
75,267
Headquarters
Basel, Switzerland
Website
Novartis AG Metrics
BasicAdvanced
€256B
21.45
€6.26
0.46
€4.09
3.04%
Price and volume
Market cap
€256B
Beta
0.46
52-week high
€144.30
52-week low
€86.43
Average daily volume
9.6K
Dividend rate
€4.09
Financial strength
Current ratio
1.117
Quick ratio
0.82
Long term debt to equity
63.572
Total debt to equity
76.171
Dividend payout ratio (TTM)
55.91%
Interest coverage (TTM)
16.61%
Profitability
EBITDA (TTM)
20,560.705
Gross margin (TTM)
75.97%
Net profit margin (TTM)
24.67%
Operating margin (TTM)
33.53%
Effective tax rate (TTM)
14.59%
Revenue per employee (TTM)
€656,940
Management effectiveness
Return on assets (TTM)
11.14%
Return on equity (TTM)
30.81%
Valuation
Price to earnings (TTM)
21.45
Price to revenue (TTM)
5.247
Price to book
5.02
Price to tangible book (TTM)
-26.17
Price to free cash flow (TTM)
19.3
Free cash flow yield (TTM)
5.18%
Free cash flow per share (TTM)
6.961
Dividend yield (TTM)
3.04%
Forward dividend yield
3.04%
Growth
Revenue change (TTM)
9.57%
Earnings per share change (TTM)
21.81%
3-year revenue growth (CAGR)
9.25%
10-year revenue growth (CAGR)
1.18%
3-year earnings per share growth (CAGR)
31.11%
10-year earnings per share growth (CAGR)
-0.20%
3-year dividend per share growth (CAGR)
10.48%
10-year dividend per share growth (CAGR)
5.64%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novartis AG stock?
Novartis AG (NOVN) has a market cap of €256B as of March 15, 2026.
What is the P/E ratio for Novartis AG stock?
The price to earnings (P/E) ratio for Novartis AG (NOVN) stock is 21.45 as of March 15, 2026.
Does Novartis AG stock pay dividends?
Yes, the Novartis AG (NOVN) stock pays dividends to shareholders. As of March 15, 2026, the dividend rate is €4.08851 and the yield is 3.04%. Novartis AG has a payout ratio of 55.91% on a trailing twelve-month basis.
When is the next Novartis AG dividend payment date?
The next Novartis AG (NOVN) dividend payment date is unconfirmed.
What is the beta indicator for Novartis AG?
Novartis AG (NOVN) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.